(Circulation. 2000;101:1282.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From The New York Hospital-Cornell Medical Center, New York, NY (S.M., K.M.S., S.M.M., D.J.S., M.A.S., B.B.L.); Zoll Medical Corporation, Burlington, Mass (S.A.); University of Pittsburgh Medical Center, Pittsburgh, Pa (D.S., D.C.); and Cleveland Clinic Foundation, Cleveland, Ohio (P.J.T.).
Correspondence to Bruce B. Lerman, MD, Division of Cardiology, The New York Hospital-Cornell Medical Center, 525 East 68th Street, Starr 4, New York, NY 10021. E-mail blerman{at}mail.med.cornell.edu
BackgroundClinical studies have shown that biphasic shocks are more effective than monophasic shocks for ventricular defibrillation. The purpose of this study was to compare the efficacy of a rectilinear biphasic waveform with a standard damped sine wave monophasic waveform for the transthoracic cardioversion of atrial fibrillation.
Methods and ResultsIn this prospective, randomized, multicenter
trial, patients undergoing transthoracic cardioversion of
atrial fibrillation were randomized to receive either damped sine wave
monophasic or rectilinear biphasic shocks. Patients randomized to the
monophasic protocol (n=77) received sequential shocks of 100, 200, 300,
and 360 J. Patients randomized to the biphasic protocol (n=88) received
sequential shocks of 70, 120, 150, and 170 J. First-shock efficacy with
the 70-J biphasic waveform (60 of 88 patients, 68%) was significantly
greater than that with the 100-J monophasic waveform (16 of 77
patients, 21%, P<0.0001), and it was achieved with
50% less delivered current (11±1 versus 22±4 A,
P<0.0001). Similarly, the cumulative efficacy with the
biphasic waveform (83 of 88 patients, 94%) was significantly greater
than that with the monophasic waveform (61 of 77 patients, 79%;
P=0.005). The following 3 variables were
independently associated with successful cardioversion: use of a
biphasic waveform (relative risk, 4.2; 95% confidence intervals, 1.3
to 13.9; P=0.02), transthoracic impedance
(relative risk, 0.64 per 10-
increase in impedance; 95% confidence
intervals, 0.46 to 0.90; P=0.005), and duration of
atrial fibrillation (relative risk, 0.97 per 30 days of atrial
fibrillation; 95% confidence intervals, 0.96 to 0.99;
P=0.02).
ConclusionsFor transthoracic cardioversion of atrial fibrillation, rectilinear biphasic shocks have greater efficacy (and require less energy) than damped sine wave monophasic shocks.
Key Words: cardioversion atrial fibrillation shock
This article has been cited by other articles:
![]() |
I. Cakulev, I. R. Efimov, and A. L. Waldo Cardioversion: Past, Present, and Future Circulation, October 20, 2009; 120(16): 1623 - 1632. [Full Text] [PDF] |
||||
![]() |
A. Mazza, M. G. Bendini, M. Cristofori, S. Nardi, M. Leggio, R. De Cristofaro, A. Giordano, L. Cozzari, G. Giordano, and R. Cappato Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables Europace, July 1, 2009; 11(7): 902 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nabauer, A. Gerth, T. Limbourg, S. Schneider, M. Oeff, P. Kirchhof, A. Goette, T. Lewalter, U. Ravens, T. Meinertz, et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management Europace, April 1, 2009; 11(4): 423 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
B M Glover, S J Walsh, C J McCann, M J Moore, G Manoharan, G W N Dalzell, A McAllister, B McClements, D J McEneaney, T G Trouton, et al. Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial Heart, July 1, 2008; 94(7): 884 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA) Eur. Heart J., November 2, 2007; 28(22): 2803 - 2817. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association Europace, November 1, 2007; 9(11): 1006 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Alegret, X. Vinolas, J. Sagrista, A. Hernandez-Madrid, L. Perez, X. Sabate, L. Mont, A. Medina, and on behalf of the REVERSE Study Investigators Predictors of success and effect of biphasic energy on electrical cardioversion in patients with persistent atrial fibrillation Europace, October 1, 2007; 9(10): 942 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Manegold, C. W. Israel, J. R. Ehrlich, G. Duray, D. Pajitnev, F. T. Wegener, and S. H. Hohnloser External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application Eur. Heart J., July 2, 2007; 28(14): 1731 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Walsh, G. Manoharan, O. J. Escalona, J. Santos, N. Evans, J. McC. Anderson, M. Stevenson, J. D. Allen, and A.A. J. Adgey Novel rectangular biphasic and monophasic waveforms delivered by a radiofrequency-powered defibrillator compared with conventional capacitor-based waveforms in transvenous cardioversion of atrial fibrillation. Europace, October 1, 2006; 8(10): 873 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF] |
||||
![]() |
N. Dagres, G. Karatasakis, F. Panou, G. Athanassopoulos, T. Maounis, E. Tsougos, K. Kourea, I. Malakos, D. Th. Kremastinos, and D. V. Cokkinos Pre-treatment with Irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation Eur. Heart J., September 1, 2006; 27(17): 2062 - 2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF] |
||||
![]() |
S. Stec, A. Gorecki, B. Zaborska, and P. Kulakowski A simple point score system for predicting the efficacy of external rectilinear biphasic cardioversion for persistent atrial fibrillation. Europace, April 1, 2006; 8(4): 297 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
Part 5: Electrical Therapies: Automated External Defibrillators, Defibrillation, Cardioversion, and Pacing Circulation, December 13, 2005; 112(24_suppl): IV-35 - IV-46. [Full Text] [PDF] |
||||
![]() |
P. McKeown and A. E. Epstein Future Directions: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery Chest, August 1, 2005; 128(2_suppl): 61S - 64S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Walsh, D. McCarty, A. J.J. McClelland, C. G. Owens, T. G. Trouton, M. T. Harbinson, S. O'Mullan, A. McAllister, B. M. McClements, M. Stevenson, et al. Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions Eur. Heart J., July 1, 2005; 26(13): 1298 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, G. Monnig, K. Wasmer, A. Heinecke, G. Breithardt, L. Eckardt, and D. Bocker A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA) Eur. Heart J., July 1, 2005; 26(13): 1292 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zohar, M. Kovacic, M. Brezocnik, and M. Podbregar Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling Europace, January 1, 2005; 7(5): 500 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sticherling, S. Behrens, W. Kamke, A. Stahn, and M. Zabel Comparison of acute and long-term effects of single-dose amiodarone and verapamil for the treatment of immediate recurrences of atrial fibrillation after transthoracic cardioversion Europace, January 1, 2005; 7(6): 546 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J B Hubner, S Gupta, and I McClellan Simplified cardioversion service with intravenous midazolam Heart, December 1, 2004; 90(12): 1447 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
A A J Adgey and S J Walsh Theory and practice of defibrillation: (1) Atrial fibrillation and DC conversion Heart, December 1, 2004; 90(12): 1493 - 1498. [Full Text] [PDF] |
||||
![]() |
D Pavin, H Legrand, C Leclercq, C Crocq, P Mabo, and J C Daubert Transvenous low energy internal cardioversion for atrial fibrillation refractory to external cardioversion: do non-obese patients benefit? Heart, March 1, 2004; 90(3): 332 - 333. [Full Text] [PDF] |
||||
![]() |
K. S. Channer, A. Birchall, R. P. Steeds, S. J. Walters, W. W. Yeo, J. N. West, R. Muthusamy, W. E. Rhoden, B. T. Saeed, P. Batin, et al. A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation Eur. Heart J., January 2, 2004; 25(2): 144 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography Ann Intern Med, December 16, 2003; 139(12): 1018 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Scholten, T Szili-Torok, P Klootwijk, and L Jordaens Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation Heart, September 1, 2003; 89(9): 1032 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
Ph. Ricard, K. Yaici, J.P. Rinaldi, M. Bergonzi, and N. Saoudi Cardioversion of atrial fibrillation: how and when? Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H40 - H44. [Abstract] [PDF] |
||||
![]() |
S K S Lairikyengbam, M H Anderson, and A G Davies Present treatment options for atrial fibrillation Postgrad. Med. J., February 1, 2003; 79(928): 67 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sticherling, M. Ozaydin, H. Tada, H. Oral, F. Pelosi, B. P. Knight, S. A. Strickberger, and F. Morady Comparison of Verapamil and Ibutilide for the Suppression of Immediate Recurrences of Atrial Fibrillation after Transthoracic Cardioversion Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 155 - 160. [Abstract] [PDF] |
||||
![]() |
R. L. Page, R. E. Kerber, J. K. Russell, T. Trouton, J. Waktare, D. Gallik, J. E. Olgin, P. Ricard, G. W. Dalzell, R. Reddy, et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: The results of an international randomized, double-blind multicenter trial J. Am. Coll. Cardiol., June 19, 2002; 39(12): 1956 - 1963. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Aronow Management of the Older Person With Atrial Fibrillation J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2002; 57(6): M352 - 363. [Abstract] [Full Text] |
||||
![]() |
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266. [Full Text] [PDF] |
||||
![]() |
R. H. Falk Atrial Fibrillation N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078. [Full Text] [PDF] |
||||
![]() |
H. J. G. M. Crijns Internal cardioversion as a first-line method of cardioversion? Europace, January 1, 2001; 3(1): 2 - 3. [PDF] |
||||
![]() |
Biphasic Better Than Monophasic Shock in AF? Journal Watch Emergency Medicine, June 1, 2000; 2000(601): 3 - 3. [Full Text] |
||||
![]() |
No Shock That Biphasics Are Better for Cardioversion of AF Journal Watch Cardiology, May 5, 2000; 2000(505): 9 - 9. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |